Clinical Study

Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)

Posted Date: Jul 20, 2017

  • Investigator: John Morris
  • Co-Investigator: Sarah Elizabeth Figueira
  • Specialties: Hematology/Oncology, Oncology, Cancer, Lung Cancer
  • Type of Study: Drug

The purpose of this research study is to examine lung cancer patients’ surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic

Criteria:

To Be Eligible For This Study, Patients Must Have A Lung Cancer Tumor Which Has Already Been Surgically Removed Or Will Be Removed.

Keywords:

Cancer, Lung, Surgery, A151216, Marker

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.